NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

Cover of Drugs and Lactation Database (LactMed)

Drugs and Lactation Database (LactMed) [Internet].

Show details

Teriflunomide

Last Revision: May 17, 2021.

Estimated reading time: 1 minute

CASRN: 163451-81-8

image 135263629 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

Because there is no published experience with teriflunomide during breastfeeding, it should be avoided during breastfeeding, especially while nursing a newborn or preterm infant.[1-3]

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

(Multiple Sclerosis) Glatiramer, Immune Globulin, Interferon Beta, Methylprednisolone

References

1.
Bove R, Alwan S, Friedman JM, et al. Management of multiple sclerosis during pregnancy and the reproductive years: A systematic review. Obstet Gynecol. 2014;124:1157–68. [PubMed: 25415167]
2.
Almas S, Vance J, Baker T, et al. Management of multiple sclerosis in the breastfeeding mother. Mult Scler Int. 2016;2016:6527458. [PMC free article: PMC4757692] [PubMed: 26966579]
3.
Dobson R, Dassan P, Roberts M, et al. UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines. Pract Neurol. 2019;19:106–14. [PubMed: 30612100]

Substance Identification

Substance Name

Teriflunomide

CAS Registry Number

163451-81-8

Drug Class

Breast Feeding

Lactation

Immunosuppressive Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Views

Related information

Similar articles in PubMed

  • Review Leflunomide[Drugs and Lactation Database (...]
    Review Leflunomide
    . Drugs and Lactation Database (LactMed). 2006
  • Review Entacapone[Drugs and Lactation Database (...]
    Review Entacapone
    . Drugs and Lactation Database (LactMed). 2006
  • Review Siponimod[Drugs and Lactation Database (...]
    Review Siponimod
    . Drugs and Lactation Database (LactMed). 2006
  • Review Neratanib[Drugs and Lactation Database (...]
    Review Neratanib
    . Drugs and Lactation Database (LactMed). 2006
  • Review Fluoxetine[Drugs and Lactation Database (...]
    Review Fluoxetine
    . Drugs and Lactation Database (LactMed). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...